RCKT

Rocket Pharmaceuticals, Inc.

20.66 USD
-0.02 (-0.10%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Rocket Pharmaceuticals, Inc. stock is down -9.51% since 30 days ago. The next earnings date is Aug 8, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 9 June’s closed higher than May. In the last 1 Unusual Options Trades, there were 1 CALL.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
17 May 14:18 19 Jul, 2024 25.00 CALL 437 370

About Rocket Pharmaceuticals, Inc.

Rocket Pharmaceuticals, Inc. focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells. The company also has a clinical stage in vitro virus program for Danon disease, a multi-organ lysosomal-associated disorder leading to early death due to heart failure.